The extension of intellectual property through secrecy of drugs registration: obstacles to the generic drug policy
Year: 2009
Type: article
Abstract: tion in terms of countries.The main producer countries according to IMS Health (2006) are: North America (54%), Europe -the largest five 1 (25%), Japan (15%).The ten world largest pharmaceutical companies are responsible for almost 50% of this market 2 .However, none of them has market share greater than 10%.This is because the concentration in this sector occurs per therapeutical classes (Hasenclever et al. 2000), because
Source: Reciis
Authors: Lia Hasenclever, Julia Paranhos, Vitor Paiva
Institution: Universidade Federal do Rio de Janeiro
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: diamond
OpenAlex ID: W2020909100